Jubilant Life Sciences

Rediff.com » News » Jubilant Life Sciences

News for Jubilant Life Sciences

News
Business
Sports

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Hetero Healthcare on Wednesday said is set to deliver 20,000 vials of its antiviral drug Covifor (remdesivir) across the country for the treatment of COVID-19, at a maximum retail price of Rs 5,400......

Meet IAF's Women Agniveers

'Training was incredible and thrilling, be it firing weapons, drill or 10 km runs and push-ups. It gave us unforgettable memories and inculcated soldier like qualities.' This Women's Day, a cheer......

Health ministry okays HCQ for early course of COVID-19

The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the......

Chandrayan-3 goes where no one has been before -- Moon's south pole

With its eyes set on becoming a major space power, India on Friday successfully launched its third Moon mission, this time a far more complicated 41-day voyage to reach the lunar south pole where......

REWIND: India in the last 24 hours

Here's a recap of events that occurred in India in the past 24 hours. Prime Minister Narendra Modi tries his hand on a charkha at a ceremony to distribute charkhas to women before the National......

Jhunjhunwala's portfolio gained Rs 2618 cr in April-July

Among the lot, Rallis India, Escorts, Jubilant Life Sciences, and Crisil added half of the total gains made in the ace stock-picker’s portfolio. The value of investments made by ace......

Which stocks are there in Rakesh Jhunjhunwala's basket?

Jhunjhunwala holds a stake in more than 30 listed firms. Investor Rakesh Jhunjhunwala, known for spotting multi-baggers, has increased stakes in two firms and offloaded in one, the latest......

3 Indian pharma cos recall products in US market

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug......

Jhunjhunwala rejigged stake in 11 firms in Q4

Currently, the investor and his family’s net worth in listed firms stands at Rs 8,517 crore, compared to Rs 8,388 crore as of March 31, 2020. Investor Rakesh Jhunjhunwala rejigged his stake......

Rakesh Jhunjhunwala rejigs portfolio in Q2; ups stake in Lupin, Tata Motors

The duo bought additional shares in pharmaceutical companies Lupin and Jubilant Life Sciences, along with Agro Tech Foods and NCC during Q2FY21. Stocks of pharmaceutical and fast moving consumer......

'Couldn't have asked for greater reward'

IMAGE: India's Neeraj Chopra competes in the Men's Javelin Throw Final at the Tokyo 2020 Olympic Games at Olympic Stadium in Tokyo on Saturday. Photograph: Christian Petersen/Getty Images......

'They said we didn't deserve to be here. We have answered them now'

When minnows Jammu and Kashmir defeated 40-times Ranji Trophy champions Mumbai on Wednesday, it was perhaps the biggest-ever shock victory in domestic Indian cricket. Rediff.com's Vaihayasi Pande......